RATIONALE: Synchronized release of Ca²⁺ into the cytosol during each cardiac cycle determines cardiomyocyte contraction. OBJECTIVE: We investigated synchrony of cytosolic [Ca²⁺] decay during diastole and the impact of cardiac remodeling. METHODS AND RESULTS: Local cytosolic [Ca²⁺] transients (1-µm intervals) were recorded in murine, porcine, and human ventricular single cardiomyocytes. We identified intracellular regions of slow (slowCaR) and fast (fastCaR) [Ca²⁺] decay based on the local time constants of decay (TAUlocal). The SD of TAUlocal as a measure of dyssynchrony was not related to the amplitude or the timing of local Ca²⁺ release. Stimulation of sarcoplasmic reticulum Ca²⁺ ATPase with forskolin or istaroxime accelerated and its inhibition with cyclopiazonic acid slowed TAUlocal significantly more in slowCaR, thus altering the relationship between SD of TAUlocal and global [Ca²⁺] decay (TAUglobal). Na⁺/Ca²⁺ exchanger inhibitor SEA0400 prolonged TAUlocal similarly in slowCaR and fastCaR. FastCaR were associated with increased mitochondrial density and were more sensitive to the mitochondrial Ca²⁺ uniporter blocker Ru360. Variation in TAUlocal was higher in pig and human cardiomyocytes and higher with increased stimulation frequency (2 Hz). TAUlocal correlated with local sarcomere relengthening. In mice with myocardial hypertrophy after transverse aortic constriction, in pigs with chronic myocardial ischemia, and in end-stage human heart failure, variation in TAUlocal was increased and related to cardiomyocyte hypertrophy and increased mitochondrial density. CONCLUSIONS: In cardiomyocytes, cytosolic [Ca²⁺] decay is regulated locally and related to local sarcomere relengthening. Dyssynchronous intracellular [Ca²⁺] decay in cardiac remodeling and end-stage heart failure suggests a novel mechanism of cellular contractile dysfunction.
RATIONALE: Synchronized release of Ca²⁺ into the cytosol during each cardiac cycle determines cardiomyocyte contraction. OBJECTIVE: We investigated synchrony of cytosolic [Ca²⁺] decay during diastole and the impact of cardiac remodeling. METHODS AND RESULTS: Local cytosolic [Ca²⁺] transients (1-µm intervals) were recorded in murine, porcine, and human ventricular single cardiomyocytes. We identified intracellular regions of slow (slowCaR) and fast (fastCaR) [Ca²⁺] decay based on the local time constants of decay (TAUlocal). The SD of TAUlocal as a measure of dyssynchrony was not related to the amplitude or the timing of local Ca²⁺ release. Stimulation of sarcoplasmic reticulum Ca²⁺ ATPase with forskolin or istaroxime accelerated and its inhibition with cyclopiazonic acid slowed TAUlocal significantly more in slowCaR, thus altering the relationship between SD of TAUlocal and global [Ca²⁺] decay (TAUglobal). Na⁺/Ca²⁺ exchanger inhibitor SEA0400 prolonged TAUlocal similarly in slowCaR and fastCaR. FastCaR were associated with increased mitochondrial density and were more sensitive to the mitochondrial Ca²⁺ uniporter blocker Ru360. Variation in TAUlocal was higher in pig and human cardiomyocytes and higher with increased stimulation frequency (2 Hz). TAUlocal correlated with local sarcomere relengthening. In mice with myocardial hypertrophy after transverse aortic constriction, in pigs with chronic myocardial ischemia, and in end-stage human heart failure, variation in TAUlocal was increased and related to cardiomyocyte hypertrophy and increased mitochondrial density. CONCLUSIONS: In cardiomyocytes, cytosolic [Ca²⁺] decay is regulated locally and related to local sarcomere relengthening. Dyssynchronous intracellular [Ca²⁺] decay in cardiac remodeling and end-stage heart failure suggests a novel mechanism of cellular contractile dysfunction.
Authors: Camila Lopez-Crisosto; Christian Pennanen; Cesar Vasquez-Trincado; Pablo E Morales; Roberto Bravo-Sagua; Andrew F G Quest; Mario Chiong; Sergio Lavandero Journal: Nat Rev Cardiol Date: 2017-03-09 Impact factor: 32.419
Authors: Ketaki N Mhatre; Paulina Wakula; Oliver Klein; Egbert Bisping; Jakob Völkl; Burkert Pieske; Frank R Heinzel Journal: Cell Mol Life Sci Date: 2018-07-30 Impact factor: 9.261
Authors: Kenneth Lim; Stephen M S Ting; Thomas Hamborg; Gordon McGregor; David Oxborough; Claudia Tomkins; Dihua Xu; Ravi Thadhani; Gregory Lewis; Rosemary Bland; Prithwish Banerjee; Simon Fletcher; Nithya S Krishnan; Robert Higgins; Daniel Zehnder; Thomas F Hiemstra Journal: JAMA Cardiol Date: 2020-04-01 Impact factor: 14.676
Authors: Matthew P Klassen; Christian J Peters; Shiwei Zhou; Hannah H Williams; Lily Yeh Jan; Yuh Nung Jan Journal: Elife Date: 2017-03-22 Impact factor: 8.140
Authors: Felix Hohendanner; Stefanie Walther; Joshua T Maxwell; Sarah Kettlewell; Sawsan Awad; Godfrey L Smith; Vassyl A Lonchyna; Lothar A Blatter Journal: J Physiol Date: 2014-12-22 Impact factor: 5.182
Authors: David Bode; Diana Lindner; Michael Schwarzl; Dirk Westermann; Peter Deissler; Uwe Primessnig; Niklas Hegemann; Lothar A Blatter; Sophie van Linthout; Carsten Tschöpe; Felix Schoenrath; Sajjad Soltani; Christof Stamm; Volker Duesterhoeft; Natale Rolim; Ulrik Wisløff; Christoph Knosalla; Volkmar Falk; Burkert M Pieske; Frank R Heinzel; Felix Hohendanner Journal: J Mol Cell Cardiol Date: 2019-04-18 Impact factor: 5.000